Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02377440 · ClinicalTrials.gov registry record
Effects of ACEI on Bone Turnover
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 32
- Enrollment target
NCT02377440 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 32 participants.
The verdict
NCT02377440 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The investigators hypothesize that older persons (≥45 years) treated with ACEI for HTN control will have: i) improved status of bone turnover (decreased P1NP and CTX), and ii) decreased levels of RANKL and RANKL/OPG, compared to those not treated with ACEI and not using RAS-related medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02377440
The ClinicalTrials.gov registry entry for NCT02377440 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02377440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02377440 about?
NCT02377440 is a clinical study titled "Effects of ACEI on Bone Turnover". The investigators hypothesize that older persons (≥45 years) treated with ACEI for HTN control will have: i) improved status of bone turnover (decreased P1NP and CTX), and ii) decreased levels of RANKL and RANKL/OPG, compared to those not treated with ACEI and not using RAS-related medications
What is the current status of trial NCT02377440?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2013-10. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT02377440?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.